Effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular risk indices in renal cell carcinoma.

Author: , AmabileMaria Ida, CianciRosario, GalaniAlessandro, ImbimboGiovanni, LaiSilvia, MazzaferroSandro, MazzarellaAngelo, MitterhoferAnna Paola, MolfinoAlessio, PasqualiMarzia

Paper Details 
Original Abstract of the Article :
Sunitinib is a standard treatment for metastatic renal cell carcinoma (RCC). Currently, the data available on the effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular (CV) risk factors are limited, and we aimed to evaluate these aspects in patients with RCC after a ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286450/

データ提供:米国国立医学図書館(NLM)

Exploring the Cardiovascular Impact of Sunitinib

The vast desert of cancer treatment is constantly evolving, with new therapies emerging to combat this formidable foe. This study delves into the potential cardiovascular effects of sunitinib, a standard treatment for metastatic renal cell carcinoma (RCC). The researchers investigated the effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular risk factors in patients with RCC after a short period of treatment.

Sunitinib's Potential Impact on Cardiovascular Health

The study found that [研究結果]. This finding suggests that [社会的な意義] and underscores the importance of careful monitoring for cardiovascular complications in patients receiving sunitinib.

Navigating the Treatment of RCC

The research provides valuable insights for patients and clinicians managing RCC. The study found that [研究結果]. It is crucial to consult with a healthcare provider to discuss potential risks and benefits of sunitinib and to develop a personalized treatment plan that minimizes cardiovascular risks.

Dr.Camel's Conclusion

This study provides a glimpse into the complex landscape of cancer treatment, where new therapies, like sunitinib, offer hope but may also come with potential side effects. The research highlights the need for careful monitoring and personalized management to mitigate cardiovascular risks and optimize patient outcomes. Continued research is needed to fully understand the long-term effects of sunitinib on cardiovascular health and to develop strategies for minimizing these risks.
Date :
  1. Date Completed 2021-05-13
  2. Date Revised 2021-05-13
Further Info :

Pubmed ID

32270594

DOI: Digital Object Identifier

PMC7286450

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.